Psychiatry Consortium funds project investigating new schizophrenia treatments
Project will see the University of Oxford partner with the Earlham Institute, Biogen and Boehringer Ingelheim
Read More
Tag: Psychiatry Consortium
Medicines Discovery Catapult, MQ, Alzheimer’s Research UK form alliance
The partnership will focus on identifying and validating novel drug targets for unmet therapeutic needs for psychiatric symptoms affecting people with mental health conditions
Read More
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
